Success Story: NIW Approved for a Cardiac Therapy Researcher Focused on Heart Failure Models
Client’s Testimonial:
“Thank you very much for your assistance with everything in getting this I-140 approval!”
On January 21st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Professor in the Field of Cellular and Pharmacological Cardiac Therapy (Approval Notice).
General Field: Cellular and Pharmacological Cardiac Therapy
Position at the Time of Case Filing: Assistant Professor
Country of Origin: India
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: January 21st, 2026
Processing Time: 4 months, 1 day
Case Summary:
In cardiovascular research, progress often depends on whether a scientist can connect mechanistic insight to therapies that demonstrate efficacy in realistic disease settings. In this NIW case, the client built a specialized record in cellular and pharmacological cardiac therapy focused on investigating cardiac physiology in the context of heart failure using mouse models, with the goal of facilitating successful therapeutic interventions for cardiovascular diseases. Our firm presented the case around that practical impact, showing how the client’s research helps identify therapeutic targets and evaluate intervention strategies in ways that can improve treatment pathways for heart failure and related conditions.
With a Ph.D. in Regenerative Therapies, the client has developed deep technical expertise in cardiac therapy research, including evaluating pharmacological compounds and cell-derived products in disease-relevant models. The petition also highlighted that the client is currently employed as an assistant professor in a U.S. university setting, reinforcing that the client is actively positioned to continue advancing this research direction in the United States.
To demonstrate that the endeavor has substantial merit and national importance, we framed the client’s work as directly aligned with urgent public health needs tied to cardiovascular diseases. Rather than relying on broad claims, we emphasized that the client’s research provides actionable insight into how heart failure develops and progresses and how interventions can be designed and tested to improve outcomes. We also highlighted that this work supports translational decision-making by strengthening the evidence base for therapeutic development.
The client’s influence was supported by measurable research uptake. At the time of filing, the client had authored 26 peer-reviewed journal articles (8 first-authored), 2 preprints (1 first-authored), and 39 abstracts (10 first-authored). The client’s work has been cited 530 times. Rather than presenting these metrics in isolation, we explained how an adjudicator could reasonably interpret the citation record as evidence of independent reliance, meaning other researchers repeatedly used the client’s findings to inform and validate their own investigations. We also provided additional context that multiple publications ranked among the most highly cited in Clinical Medicine for their publication years, including one paper in the top 1% and additional papers in top citation percentile tiers, which helped translate citation totals into a clearer measure of field influence.
Professional trust further reinforced the client’s standing. The client has completed at least 5 peer reviews, which we presented as selective recognition because review invitations typically reflect confidence in the reviewer’s expertise and judgment. The petition also included evidence of major funding sources supporting research aligned with the client’s work, which we framed as objective reinforcement that the research direction has attracted meaningful institutional support.
To strengthen the record, we included 4 letters of recommendation from experts in the field. These letters helped translate specialized cardiac therapy research into clear significance and corroborated the objective evidence of originality, influence, and continued relevance.
“[Client’s] trusted leadership is evidenced through exceptional findings and her role as an editor. [Client’s] research must continue without impediment or delay, as her projects have lifesaving translational results.”
With the evidence organized around national importance, independent reliance, and sustained peer trust, USCIS approved the client’s NIW petition. We are honored to have supported this successful outcome and extend our sincere best wishes for the client’s continued contributions to advancing therapeutic strategies for heart failure and other cardiovascular diseases in the United States.